Literature DB >> 29255237

Palliative care: Anamorelin provides benefit to patients with cachexia.

Peter Sidaway.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29255237     DOI： 10.1038/nrclinonc.2017.204

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).

Authors:  Nobuyuki Katakami; Junji Uchino; Takuma Yokoyama; Tateaki Naito; Masashi Kondo; Kouzo Yamada; Hiromoto Kitajima; Kozo Yoshimori; Kazuhiro Sato; Hiroshi Saito; Keisuke Aoe; Tetsuya Tsuji; Yuichi Takiguchi; Koichi Takayama; Naoyuki Komura; Toru Takiguchi; Kenji Eguchi
Journal:  Cancer       Date:  2017-12-04       Impact factor: 6.860
  1 in total
  1 in total

Review 1.  Research Progress of Liujunzi Decoction in the Treatment of Tumor-Associated Anorexia.

Authors:  Xipei Wu; Yongzhao Dai; Ke Nie
Journal:  Drug Des Devel Ther       Date:  2022-06-07       Impact factor: 4.319
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.